Christer Frode Aas1,2, Jørn Henrik Vold3,4, Rolf Gjestad5, Svetlana Skurtveit6,7, Aaron Guanliang Lim8, Kristian Varden Gjerde5, Else-Marie Løberg3,5,9, Kjell Arne Johansson3,4, Lars Thore Fadnes3,4. 1. Bergen Addiction Research group, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway. christer.frode.aas@helse-bergen.no. 2. Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway. christer.frode.aas@helse-bergen.no. 3. Bergen Addiction Research group, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway. 4. Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway. 5. Division of Psychiatry, Haukeland University Hospital, Bergen, Norway. 6. Norwegian Centre for Addiction Research, University of Oslo, Oslo, Norway. 7. Department of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway. 8. Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK. 9. Department of Clinical Psychology, University of Bergen, Bergen, Norway.
Abstract
BACKGROUND: There is high co-occurrence of substance use disorders (SUD) and mental health disorders. We aimed to assess impact of substance use patterns and sociodemographic factors on mental health distress using the ten-item Hopkins Symptom Checklist (SCL-10) over time. METHODS: Nested prospective cohort study of 707 participants with severe SUD across nine opioid-agonist-therapy outpatient clinics and low-threshold municipality clinics in Norway, during 2017-2020. Descriptive statistics were derived at baseline and reported by means and standard deviation (SD). A linear mixed model analysis was used to assess the impact of substance use patterns and sociodemographic factors on SCL-10 sum score with beta coefficients with 95% confidence intervals (CI). RESULTS: Mean (SD) SCL-10 score was 2.2 (0.8) at baseline with large variations across patients. We observed more symptoms of mental health disorders among people with frequent use of benzodiazepines (beta 3.6, CI:2.4;4.8), cannabis (1.3, CI:0.2;2.5), opioids (2.7, CI:1.1;4.2), and less symptoms among people using frequent stimulant use (- 2.7, CI:-4.1;-1.4) compared to no or less frequent use. Females (1.8, CI:0.7;3.0) and participants with debt worries (2.2, CI:1.1;3.3) and unstable living conditions (1.7, CI:0.0;3.3) had also higher burden of mental health symptoms. There were large individual variations in SCL-10 score from baseline to follow-up, but no consistent time trends indicating change over time for the whole group. 65% of the cohort had a mean score > 1.85, the standard reference score. CONCLUSIONS: People with SUD have a considerable burden of mental health symptoms. We found no association between substance use patterns and change in mental health symptoms over time. This could suggest that the differences observed were indicating flattening of effects or self-medication to a larger degree than medication-related decline in mental health. This call for better individualized mental health assessment and patient care.
BACKGROUND: There is high co-occurrence of substance use disorders (SUD) and mental health disorders. We aimed to assess impact of substance use patterns and sociodemographic factors on mental health distress using the ten-item Hopkins Symptom Checklist (SCL-10) over time. METHODS: Nested prospective cohort study of 707 participants with severe SUD across nine opioid-agonist-therapy outpatient clinics and low-threshold municipality clinics in Norway, during 2017-2020. Descriptive statistics were derived at baseline and reported by means and standard deviation (SD). A linear mixed model analysis was used to assess the impact of substance use patterns and sociodemographic factors on SCL-10 sum score with beta coefficients with 95% confidence intervals (CI). RESULTS: Mean (SD) SCL-10 score was 2.2 (0.8) at baseline with large variations across patients. We observed more symptoms of mental health disorders among people with frequent use of benzodiazepines (beta 3.6, CI:2.4;4.8), cannabis (1.3, CI:0.2;2.5), opioids (2.7, CI:1.1;4.2), and less symptoms among people using frequent stimulant use (- 2.7, CI:-4.1;-1.4) compared to no or less frequent use. Females (1.8, CI:0.7;3.0) and participants with debt worries (2.2, CI:1.1;3.3) and unstable living conditions (1.7, CI:0.0;3.3) had also higher burden of mental health symptoms. There were large individual variations in SCL-10 score from baseline to follow-up, but no consistent time trends indicating change over time for the whole group. 65% of the cohort had a mean score > 1.85, the standard reference score. CONCLUSIONS:People with SUD have a considerable burden of mental health symptoms. We found no association between substance use patterns and change in mental health symptoms over time. This could suggest that the differences observed were indicating flattening of effects or self-medication to a larger degree than medication-related decline in mental health. This call for better individualized mental health assessment and patient care.
Entities:
Keywords:
Mental disorder; Mental health problems; Opioid dependence; Opioid substitution treatment; Psychological distress; Substance abuse; Substance use disorder
Authors: Bridget F Grant; Frederick S Stinson; Deborah A Dawson; S Patricia Chou; Mary C Dufour; Wilson Compton; Roger P Pickering; Kenneth Kaplan Journal: Arch Gen Psychiatry Date: 2004-08
Authors: Else-Marie Løberg; Siri Helle; Merethe Nygård; Jan Øystein Berle; Rune A Kroken; Erik Johnsen Journal: Front Psychiatry Date: 2014-11-18 Impact factor: 4.157
Authors: Alexandra M Franklyn; Joseph K Eibl; Graham Gauthier; David Pellegrini; Nancy E Lightfoot; David C Marsh Journal: Harm Reduct J Date: 2017-01-26
Authors: Jørn Henrik Vold; Christer Aas; Svetlana Skurtveit; Ingvild Odsbu; Fatemeh Chalabianloo; Johan Reutfors; Anne Halmøy; Kjell Arne Johansson; Lars Thore Fadnes Journal: BMJ Open Date: 2020-08-07 Impact factor: 2.692
Authors: Mitra Bemanian; Jørn Henrik Vold; Ranadip Chowdhury; Christer Frode Aas; Rolf Gjestad; Kjell Arne Johansson; Lars Thore Fadnes Journal: Int J Environ Res Public Health Date: 2022-05-09 Impact factor: 4.614
Authors: Lars T Fadnes; Einar Furulund; Karl Trygve Druckrey-Fiskaaen; Tesfaye Madebo; Jørn Henrik Vold; Maria Olsvold; Marianne Cook Pierron; Siv-Elin Leirvåg Carlsen; Rune Blomhoff; Torgeir Gilje Lid Journal: BMC Nutr Date: 2022-09-03